Related references
Note: Only part of the references are listed.5-Fluorouracil combined with cisplatin via arterial induction for advanced T-stage nasopharyngeal carcinoma: A 10-year outcome of a phase I/II study
Li Xiang et al.
FRONTIERS IN ONCOLOGY (2022)
The evaluation of adding induction chemotherapy to concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma: a meta-analysis
Min Tang et al.
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2021)
The impact of induction chemotherapy on long-term quality of life in patients with locoregionally advanced nasopharyngeal carcinoma: Outcomes from a randomised phase 3 trial
Qi Yang et al.
ORAL ONCOLOGY (2021)
Quality-Adjusted Life Years and Disability-Adjusted Life Years Are Better With Concurrent Chemoradiation Therapy Than Induction Chemotherapy Followed by Chemoradiation Therapy in Nasopharyngeal Carcinoma
Mary R. Nittala et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2021)
The efficacy and safety of docetaxel, cisplatin and fluorouracil (TPF)-based induction chemotherapy followed by concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a meta-analysis
R. Zhou et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2020)
The efficacy and safety of induction chemotherapy combined with concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in nasopharyngeal carcinoma patients: a systematic review and meta-analysis
Bi-Cheng Wang et al.
BMC CANCER (2020)
The efficacy and toxicity of induction chemotherapy plus concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma A meta-analysis of randomized controlled trials
Peirong Wang et al.
MEDICINE (2020)
A Pairwise Meta-Analysis of Induction Chemotherapy in Nasopharyngeal Carcinoma
Pu-Yun OuYang et al.
ONCOLOGIST (2019)
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
Yuan Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Induction gemcitabine and cisplatin in locoregionally advanced nasopharyngeal carcinoma
Yuan Zhang et al.
CANCER COMMUNICATIONS (2019)
Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: long-term results of a phase III multicentre randomised controlled trial
Qi Yang et al.
EUROPEAN JOURNAL OF CANCER (2019)
Concurrent chemoradiotherapy with/without induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: Long-term results of phase 3 randomized controlled trial
Wen-Fei Li et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Evolutionary role of chemotherapy in advanced nasopharyngeal carcinoma: a literature-based network meta-analysis
Li Li et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Less is more: role of additional chemotherapy to concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal cancer management
Yong Chan Ahn
RADIATION ONCOLOGY JOURNAL (2019)
Association of Chemoradiotherapy Regimens and Survival Among Patients With Nasopharyngeal Carcinoma A Systematic Review and Meta-analysis
Bin Zhang et al.
JAMA NETWORK OPEN (2019)
Which induction chemotherapy regimen followed by cisplatin-based concurrent chemoradiotherapy is the best choice among PF, TP and TPF for locoregionally advanced nasopharyngeal carcinoma?
Yan He et al.
ANNALS OF TRANSLATIONAL MEDICINE (2019)
Nomogram to predict the benefit of additional induction chemotherapy to concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: Analysis of a multicenter, phase III randomized trial
Yuan Zhang et al.
RADIOTHERAPY AND ONCOLOGY (2018)
Final results of a randomized phase III trial of induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in patients with stage IVA and IVB nasopharyngeal carcinoma-Taiwan Cooperative Oncology Group (TCOG) 1303 Study
R. L. Hong et al.
ANNALS OF ONCOLOGY (2018)
Induction Chemotherapy plus Concurrent Chemoradiotherapy in Endemic Nasopharyngeal Carcinoma: Individual Patient Data Pooled Analysis of Four Randomized Trials
Yu-Pei Chen et al.
CLINICAL CANCER RESEARCH (2018)
Induction chemotherapy for locally advanced nasopharyngeal carcinoma treated with concurrent chemoradiation: A systematic review and meta-analysis
Teng Hwee Tan et al.
RADIOTHERAPY AND ONCOLOGY (2018)
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016 A Systematic Analysis for the Global Burden of Disease Study
Christina Fitzmaurice et al.
JAMA ONCOLOGY (2018)
The Changing Role of Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: A Updated Systemic Review and Network Meta-Analysis
Mei Liu et al.
FRONTIERS IN ONCOLOGY (2018)
A randomized trial of induction docetaxel-cisplatin-5FU followed by concomitant cisplatin-RT versus concomitant cisplatin-RT in nasopharyngeal carcinoma (GORTEC 2006-02)
M. Frikha et al.
ANNALS OF ONCOLOGY (2018)
Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase III multicentre randomised controlled trial
Su-Mei Cao et al.
EUROPEAN JOURNAL OF CANCER (2017)
What Is the Best Treatment of Locally Advanced Nasopharyngeal Carcinoma? An Individual Patient Data Network Meta-Analysis
Laureen Ribassin-Majed et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
The Effect of Adding Neoadjuvant Chemotherapy to Concurrent Chemoradiotherapy in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma and Undetectable Pretreatment Epstein-Barr Virus DNA
Ya-Nan Jin et al.
TRANSLATIONAL ONCOLOGY (2017)
The Changing Therapeutic Role of Chemo-radiotherapy for Loco-regionally Advanced Nasopharyngeal Carcinoma from Two/Three-Dimensional Radiotherapy to Intensity-Modulated Radiotherapy: A Network Meta-Analysis
Rui You et al.
THERANOSTICS (2017)
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015 A Systematic Analysis for the Global Burden of Disease Study
Christina Fitzmaurice et al.
JAMA ONCOLOGY (2017)
Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial
Ying Sun et al.
LANCET ONCOLOGY (2016)
The role of induction and adjuvant chemotherapy in combination with concurrent chemoradiotherapy for nasopharyngeal cancer: a Bayesian network meta-analysis of published randomized controlled trials
Hongliang Yu et al.
ONCOTARGETS AND THERAPY (2016)
Significant benefits of adding neoadjuvant chemotherapy before concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a meta-analysis of randomized controlled trials
Mengmeng Wang et al.
ONCOTARGET (2016)
Induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma
Wen-Fei Li et al.
CHINESE JOURNAL OF CANCER (2016)
Concurrent Chemo-Radiation With or Without Induction Gemcitabine, Carboplatin, and Paclitaxel: A Randomized, Phase 2/3 Trial in Locally Advanced Nasopharyngeal Carcinoma
Terence Tan et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
Survival benefit of induction chemotherapy in treatment for locally advanced nasopharyngeal carcinoma - A time-to-event meta-analysis
Yaqi Song et al.
ORAL ONCOLOGY (2015)
Efficacy of the Additional Neoadjuvant Chemotherapy to Concurrent Chemoradiotherapy for Patients with Locoregionally Advanced Nasopharyngeal Carcinoma: a Bayesian Network Meta-analysis of Randomized Controlled Trials
Yu-Pei Chen et al.
JOURNAL OF CANCER (2015)
Induction chemotherapy followed by concomitant radiotherapy and weekly cisplatin versus the same concomitant chemoradiotherapy in patients with nasopharyngeal carcinoma: a randomized phase II study conducted by the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluation
G. Fountzilas et al.
ANNALS OF ONCOLOGY (2012)
New data tells us more about cancer incidence in North Africa
Roberto Zanetti et al.
EUROPEAN JOURNAL OF CANCER (2010)
Randomized Phase II Trial of Concurrent Cisplatin-Radiotherapy With or Without Neoadjuvant Docetaxel and Cisplatin in Advanced Nasopharyngeal Carcinoma
Edwin P. Hui et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
David Moher et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Transcriptional patterns, biomarkers and pathways characterizing nasopharyngeal carcinoma of Southern China
Weiyi Fang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2008)
The enigmatic epidemiology of nasopharyngeal carcinoma
Ellen T. Chang et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)